Skip to main content
logo
Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
46.53
+0.27 (0.58%)
Aug 5, 2026, 2:32 PM EDT - Market open

Spruce Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--4.9110.09--
Revenue Growth
---51.32%---
Gross Profit
--4.9110.09--
Operating Income
-34.01-36.51-56.15-51.99-47.28-42.07
Net Income
-33.6-38.97-53.04-47.92-46.18-42.29
Earnings Per Share
-36.60-50.83-96.40-93.00-147.00-135.75
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
54.0848.9138.7596.3479.0888.97
Total Debt
6.80.422.484.366.186.17
Net Cash (Debt)
47.2848.4936.2791.9872.982.8
Net Cash Growth
100.26%33.68%-60.57%26.17%-11.95%-45.17%
Net Cash Per Share
49.4663.2565.93179.14232.39265.82

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-29.33-33.33-55.96-33.28-41.68-35.88
Capital Expenditures
-0.01---0.01-0.01-0.09
Free Cash Flow
-29.34-33.33-55.96-33.28-41.69-35.97
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%100.00%--
Operating Margin
---1143.37%-515.34%--
Pretax Margin
---1079.94%-474.96%--
Profit Margin
---1079.94%-474.96%--
FCF Margin
---1139.56%-329.88%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--3.6111.92--